Sun BioPharma is engaged in advancing the commercial development of a proprietary polyamine analogue for pancreatic cancer. Co. has exclusively licensed the worldwide rights to this compound, which has been designated as SBP-101, from the University of Florida Research Foundation, Inc. Co.'s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition, a metabolic pathway of critical importance in multiple tumor types. We show 3 historical shares outstanding datapoints in our SNBP shares outstanding history coverage, used to compute SNBP market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SNBP market cap history over the course of time is important for investors
interested in comparing SNBP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SNBP versus a peer is one thing; comparing
SNBP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SNBP can fluctuate over the course of history.
With this page we aim to empower investors researching SNBP by allowing them to research the SNBP market cap history. |
Free SNBP Email Alerts:
Video: The Importance of Market Cap
